Saga Diagnostics logo

Saga Diagnostics

ID: 17658524

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

3

Funding Rounds

$20.4m

Money raised

Overview

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Saga Diagnostics has raised a total of $20.4m in funding over 3 rounds.

Key Insights:

  • Saga Diagnostics June 2021 Series A Funding Round: $12m
  • SAGA , June 2019: $4.2m
  • Saga Diagnostics June 2019 Series A Funding Round: $4.2m

Industries

Saga Diagnostics is active in the following industries: